2011 - 10th Meeting - IHCTAS

Plenary Session II. Part 1: Immunosuppression

3.2 - The Role of Donor Bone Marrow Chimerism in Promoting Acceptance of VCA

Presenter: Suzanne T., Ildstad, Louisville, KY, USA
Authors: Suzanne T. Ildstad

The Role of Donor Bone Marrow Chimerism in Promoting Acceptance of VCA

Suzanne T. Ildstad, Institute for Cellular Therapeutics, University of Louisville, Louisville, KY, USA.

Learning objectives:

1. Understanding of chimerism and tolerance

2. Status of current studies in chimerism in VCA

Vascularized Composite Allotransplants (VCA) are immunologically complex units, often comprised of a bone marrow component and microenvironment. Chimerism induces donor-specific tolerance. This presentation will highlight the role of donor bone marrow chimerism in promoting acceptance of VCA. It will provide a review of the current status of chimerism from bench to the bedside.

You must be logged in to view recordings

Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Our Corporate Sponsors

TTS gratefully acknowledges the Corporate Partners whose generous support makes the work of the Society possible:

  • astellas
  • roche
  • sanofi